A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications
Murphy, Susan F.
Kelly, Deborah F.
MetadataShow full item record
The lack of a rapid and quantitative autophagy assay has substantially hindered the development and implementation of autophagy-targeting therapies for a variety of human diseases. To address this critical issue, we developed a novel autophagy assay using the newly developed Cyto-ID fluorescence dye. We first verified that the Cyto-ID dye specifically labels autophagic compartments with minimal staining of lysosomes and endosomes. We then developed a new Cyto-ID fluorescence spectrophotometric assay that makes it possible to estimate autophagy flux based on measurements of the Cyto-ID-stained autophagic compartments. By comparing to traditional autophagy approaches, we found that this assay yielded a more sensitive, yet less variable, quantification of the stained autophagic compartments and the estimate of autophagy flux. Furthermore, we tested the potential application of this autophagy assay in high throughput research by integrating it into an RNA interference (RNAi) screen and a small molecule screen. The RNAi screen revealed WNK2 and MAP3K6 as autophagy-modulating genes, both of which inhibited the MTOR pathway. Similarly, the small molecule screen identified sanguinarine and actinomycin D as potent autophagy inducers in leukemic cells. Moreover, we successfully detected autophagy responses to kinase inhibitors and chloroquine in normal or leukemic mice using this assay. Collectively, this new Cyto-ID fluorescence spectrophotometric assay provides a rapid, reliable quantification of autophagic compartments and estimation of autophagy flux with potential applications in developing autophagy-related therapies and as a test to monitor autophagy responses in patients being treated with autophagy-modulating drugs.
- All Faculty Deposits 
- Scholarly Works, Department of Biochemistry 
- Scholarly Works, Department of Biological Sciences 
- Scholarly Works, Department of Biomedical Sciences and Pathobiology 
- Scholarly Works, Department of Population Health Sciences 
- Scholarly Works, Fralin Biomedical Research Institute at VTC 
- Scholarly Works, Fralin Life Sciences Institute 
- Scholarly Works, Virginia Tech Center for Drug Discovery 
Showing items related by title, author, creator and subject.
Craige, Siobhan M.; Chen, Kai; Blanton, Robert M.; Keaney, John F.; Kant, Shashi (Portland Press, 2019-07-19)Cardiometabolic syndrome (CMS) describes the cluster of metabolic and cardiovascular diseases that are generally characterized by impaired glucose tolerance, intra-abdominal adiposity, dyslipidemia, and hypertension. CMS ...
Extracellular-signal regulated kinase 8 of Trypanosoma brucei uniquely phosphorylates its proliferating cell nuclear antigen homolog and reveals exploitable properties Valenciano, A. L.; Knudsen, G. M.; Mackey, Z. B. (Taylor & Francis Inc, 2016-01-01)
The Physarum polycephalum Genome Reveals Extensive Use of Prokaryotic Two-Component and Metazoan-Type Tyrosine Kinase Signaling Schaap, P.; Barrantes, I.; Minx, P.; Sasaki, N.; Anderson, R. W.; Beinard, M.; Biggar, K. K.; Buehler, N. E.; Bundschuh, R.; Chen, X.; Fronick, C.; Fulton, L.; Golderer, G.; Jahn, N.; Knoop, V.; Landweber, L. F.; Maric, C.; Miller, D.; Noegel, A. A.; Peace, R.; Pierron, G.; Sasaki, T.; Schallenberg-Ruedinger, M.; Schleicher, M.; Singh, R.; Spaller, T.; Storey, K. B.; Suzuki, T.; Tomlinson, C.; Tyson, John J.; Warren, W. C.; Werner, E. R.; Werner-Felmayer, G.; Wilson, R. K.; Winckler, T.; Gott, J. M.; Gloeckner, G.; Marwan, W. (Oxford Univ Press, 2016-01-01)